UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)

BMC cancer, 2017-07, Vol.17 (1), p.459-459, Article 459

2017

Volltextzugriff (PDF)

A scoping review of statistical methods in studies of biomarker-related treatment heterogeneity for breast cancer

BMC medical research methodology, 2023-06, Vol.23 (1), p.154-154, Article 154

2023

Volltextzugriff (PDF)

Correction: A scoping review of statistical methods in studies of biomarker-related treatment heterogeneity for breast cancer

BMC medical research methodology, 2023-09, Vol.23 (1), p.1-202, Article 202

2023

Volltextzugriff (PDF)

A real or apparent decrease in glomerular filtration rate in patients using olaparib?

European journal of clinical pharmacology, 2021-02, Vol.77 (2), p.179-188

2021

Volltextzugriff (PDF)

Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature

Breast cancer research and treatment, 2022-07, Vol.194 (2), p.265-278

2022

Volltextzugriff (PDF)

The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07)

BMC cancer, 2015-09, Vol.15 (1), p.610, Article 610

2015

Volltextzugriff (PDF)

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy

Annals of surgical oncology, 2010-09, Vol.17 (9), p.2411-2418

2010

Volltextzugriff (PDF)

Validation of 70-gene prognosis signature in node-negative breast cancer

Breast cancer research and treatment, 2009-10, Vol.117 (3), p.483-495

2009

Volltextzugriff (PDF)

Prognostic factors for survival in metastatic breast cancer by hormone receptor status

Breast cancer research and treatment, 2014-06, Vol.145 (2), p.503-511

2014

Volltextzugriff (PDF)

Importance of highly selective LC–MS/MS analysis for the accurate quantification of tamoxifen and its metabolites: focus on endoxifen and 4-hydroxytamoxifen

Breast cancer research and treatment, 2012-06, Vol.133 (2), p.793-798

2012

Volltextzugriff (PDF)

CYP2C192 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment

Breast cancer research and treatment, 2013-06, Vol.139 (3), p.649-655

2013

Volltextzugriff (PDF)

Tamoxifen dose and serum concentrations of tamoxifen and six of its metabolites in routine clinical outpatient care

Breast cancer research and treatment, 2014-02, Vol.143 (3), p.477-483

2014

Volltextzugriff (PDF)

Use of dried blood spots for the determination of serum concentrations of tamoxifen and endoxifen

Breast cancer research and treatment, 2014-07, Vol.146 (1), p.137-144

2014

Volltextzugriff (PDF)

Response of symptomatic brain metastases from HER-2 overexpressing breast cancer with T-DM1

Journal of neuro-oncology, 2016-04, Vol.127 (2), p.401-403

2016

Volltextzugriff (PDF)

An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcome

Breast cancer research and treatment, 2017-02, Vol.161 (3), p.567-574

2017

Volltextzugriff (PDF)

Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherapy: a nationwide study

Genetics in medicine, 2016-07, Vol.18 (7), p.720-726

2016

Volltextzugriff (PDF)

BRCA1-like profile is not significantly associated with survival benefit of non-myeloablative intensified chemotherapy in the GAIN randomized controlled trial

Breast cancer research and treatment, 2017-12, Vol.166 (3), p.775-785

2017

Volltextzugriff (PDF)

Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms

Breast cancer research and treatment, 2014-06, Vol.145 (3), p.697-705

2014

Volltextzugriff (PDF)

The prognostic value of the neoadjuvant response index in triple-negative breast cancer: validation and comparison with pathological complete response as outcome measure

Breast cancer research and treatment, 2015-08, Vol.153 (1), p.145-152

2015

Volltextzugriff (PDF)

CYP2C19 2 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment

Breast cancer research and treatment, 2013-06, Vol.139 (3), p.649-655

2013

Volltextzugriff (PDF)

Gene expression profiling in breast cancer – design of a pooled database to address open questions

European surgery, 2009-10, Vol.41 (5), p.221-227

2009

Volltextzugriff (PDF)

Response of symptomatic brain metastases from HER-2 overexpressing breast cancer with T-DM1

Journal of neuro-oncology, 2016, Vol.127 (2), p.401-403

2016

Volltextzugriff (PDF)

Molecular prediction of tamoxifen resistance in breast cancer

Breast cancer research : BCR, 2005-06, Vol.7 (Suppl 2), p.P2-P2, Article P2.07

2005

Volltextzugriff (PDF)

Implications of debt renegotiation for optimal bank policy and firm behavior

Review of quantitative finance and accounting, 1997-03, Vol.8 (2), p.163-179

1997

Volltextzugriff (PDF)

Maternal lipid levels in early pregnancy as a predictor of childhood lipid levels: a prospective cohort study

BMC pregnancy and childbirth, 2022-07, Vol.22 (1), p.1-588, Article 588

2022

Volltextzugriff (PDF)

1 – 25 von 273

Suche als RSS-Feed

Aktive Filter

SpracheKatalanisch

KollektionSpringer Nature - Complete Springer Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(260)
Mit Volltextzugriff
(263)

Publikationsform

Artikel
(272)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)

A scoping review of statistical methods in studies of biomarker-related treatment heterogeneity for breast cancer

Correction: A scoping review of statistical methods in studies of biomarker-related treatment heterogeneity for breast cancer

A real or apparent decrease in glomerular filtration rate in patients using olaparib?

Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature

The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07)

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy

Validation of 70-gene prognosis signature in node-negative breast cancer

Prognostic factors for survival in metastatic breast cancer by hormone receptor status

Importance of highly selective LC–MS/MS analysis for the accurate quantification of tamoxifen and its metabolites: focus on endoxifen and 4-hydroxytamoxifen

CYP2C192 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment

Tamoxifen dose and serum concentrations of tamoxifen and six of its metabolites in routine clinical outpatient care

Use of dried blood spots for the determination of serum concentrations of tamoxifen and endoxifen

Response of symptomatic brain metastases from HER-2 overexpressing breast cancer with T-DM1

An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcome

Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherapy: a nationwide study

BRCA1-like profile is not significantly associated with survival benefit of non-myeloablative intensified chemotherapy in the GAIN randomized controlled trial

Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms

The prognostic value of the neoadjuvant response index in triple-negative breast cancer: validation and comparison with pathological complete response as outcome measure

CYP2C19 2 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment

Gene expression profiling in breast cancer – design of a pooled database to address open questions

Response of symptomatic brain metastases from HER-2 overexpressing breast cancer with T-DM1

Molecular prediction of tamoxifen resistance in breast cancer

Implications of debt renegotiation for optimal bank policy and firm behavior

Maternal lipid levels in early pregnancy as a predictor of childhood lipid levels: a prospective cohort study

Aktive Filter

Suchergebnisse filtern